Search research articles
Contact Us
Filters
Showing results (361-370 of 636) with videos related to
Page
of 64
Sort By:
The New England Journal of Medicine
|
June 24, 2022
Fazirsiran for Liver Disease Associated with Alpha<sub>1</sub>-Antitrypsin Deficiency
Pavel Strnad, Mattias Mandorfer, Gourab Choudhury, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 22, 2018
Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians
Celeste Allaband, Daniel McDonald, Yoshiki Vázquez-Baeza, et al.
Hepatology Communications
|
November 20, 2025
Association between pattern of hepatic iron deposition and severity of MASH among patients enrolled in the NASH Clinical Research Network
Aalam Sohal, Laura A Wilson, David E Kleiner, et al.
Contemporary Clinical Trials
|
July 24, 2017
Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study
A S Barritt, Norman Gitlin, Samuel Klein, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
October 19, 2013
Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects
Lindsey M Negrete, Michael S Middleton, Lisa Clark, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 26, 2018
Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis
Naga Chalasani, Manal F Abdelmalek, Rohit Loomba, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 12, 2024
Fibrosis, biomarkers and liver biopsy in AAT deficiency and relation to liver Z protein polymer accumulation
Anandini Suri, Zidong Zhang, Brent Neuschwander-Tetri, et al.
Lancet (London, England)
|
December 18, 2018
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Arun Sanyal, Edgar D Charles, Brent A Neuschwander-Tetri, et al.
European Radiology
|
February 28, 2019
Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations
Cheng William Hong, Charlie C Park, Adrija Mamidipalli, et al.
Journal of Hepatology
|
October 22, 2019
Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
Mohammad Shadab Siddiqui, Mark L Van Natta, Margery A Connelly, et al.
Page
of 64
Search research articles
Search
Showing results (361-370 of 636) with videos related to
Sort By:
Page
of 64
The New England Journal of Medicine
|
June 24, 2022
Fazirsiran for Liver Disease Associated with Alpha<sub>1</sub>-Antitrypsin Deficiency
Pavel Strnad, Mattias Mandorfer, Gourab Choudhury, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 22, 2018
Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians
Celeste Allaband, Daniel McDonald, Yoshiki Vázquez-Baeza, et al.
Hepatology Communications
|
November 20, 2025
Association between pattern of hepatic iron deposition and severity of MASH among patients enrolled in the NASH Clinical Research Network
Aalam Sohal, Laura A Wilson, David E Kleiner, et al.
Contemporary Clinical Trials
|
July 24, 2017
Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study
A S Barritt, Norman Gitlin, Samuel Klein, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
October 19, 2013
Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects
Lindsey M Negrete, Michael S Middleton, Lisa Clark, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 26, 2018
Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis
Naga Chalasani, Manal F Abdelmalek, Rohit Loomba, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 12, 2024
Fibrosis, biomarkers and liver biopsy in AAT deficiency and relation to liver Z protein polymer accumulation
Anandini Suri, Zidong Zhang, Brent Neuschwander-Tetri, et al.
Lancet (London, England)
|
December 18, 2018
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Arun Sanyal, Edgar D Charles, Brent A Neuschwander-Tetri, et al.
European Radiology
|
February 28, 2019
Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations
Cheng William Hong, Charlie C Park, Adrija Mamidipalli, et al.
Journal of Hepatology
|
October 22, 2019
Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
Mohammad Shadab Siddiqui, Mark L Van Natta, Margery A Connelly, et al.
Page
of 64